Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7P4B

HLA-E*01:03 in complex with IL9

Summary for 7P4B
Entry DOI10.2210/pdb7p4b/pdb
DescriptorHLA class I histocompatibility antigen, alpha chain E, Beta-2-microglobulin, ESAT-6-like protein EsxH, ... (8 entities in total)
Functional Keywordshla-e mhc, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains12
Total formula weight182347.10
Authors
Walters, L.C.,Gillespie, G.M. (deposition date: 2021-07-10, release date: 2022-07-27, Last modification date: 2024-10-09)
Primary citationWalters, L.C.,Rozbesky, D.,Harlos, K.,Quastel, M.,Sun, H.,Springer, S.,Rambo, R.P.,Mohammed, F.,Jones, E.Y.,McMichael, A.J.,Gillespie, G.M.
Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes.
Cell Rep, 39:110959-110959, 2022
Cited by
PubMed Abstract: MHC-E regulates NK cells by displaying MHC class Ia signal peptides (VL9) to NKG2A:CD94 receptors. MHC-E can also present sequence-diverse, lower-affinity, pathogen-derived peptides to T cell receptors (TCRs) on CD8 T cells. To understand these affinity differences, human MHC-E (HLA-E)-VL9 versus pathogen-derived peptide structures are compared. Small-angle X-ray scatter (SAXS) measures biophysical parameters in solution, allowing comparison with crystal structures. For HLA-E-VL9, there is concordance between SAXS and crystal parameters. In contrast, HLA-E-bound pathogen-derived peptides produce larger SAXS dimensions that reduce to their crystallographic dimensions only when excess peptide is supplied. Further crystallographic analysis demonstrates three amino acids, exclusive to MHC-E, that not only position VL9 close to the α2 helix, but also allow non-VL9 peptide binding with re-configuration of a key TCR-interacting α2 region. Thus, non-VL9-bound peptides introduce an alternative peptide-binding motif and surface recognition landscape, providing a likely basis for VL9- and non-VL9-HLA-E immune discrimination.
PubMed: 35705051
DOI: 10.1016/j.celrep.2022.110959
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.72 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon